Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51
Founded in 1991, Camurus has grown into a $4B biotech with two products in the...
As Sweden’s most valuable biotech company, Camurus stands out with its unique platform for the sustained release of therapies. With multiple products on the market, Camurus is a key player in both the biotech and pharmaceutical industries.
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.